AU2713100A - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- AU2713100A AU2713100A AU27131/00A AU2713100A AU2713100A AU 2713100 A AU2713100 A AU 2713100A AU 27131/00 A AU27131/00 A AU 27131/00A AU 2713100 A AU2713100 A AU 2713100A AU 2713100 A AU2713100 A AU 2713100A
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11414398P | 1998-12-23 | 1998-12-23 | |
US60114143 | 1998-12-23 | ||
PCT/US1999/030602 WO2000039115A1 (en) | 1998-12-23 | 1999-12-21 | Protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2713100A true AU2713100A (en) | 2000-07-31 |
Family
ID=22353596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27131/00A Abandoned AU2713100A (en) | 1998-12-23 | 1999-12-21 | Protease inhibitors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1140897A4 (en) |
JP (1) | JP2002533452A (en) |
AR (1) | AR021970A1 (en) |
AU (1) | AU2713100A (en) |
CO (1) | CO5180541A1 (en) |
DZ (1) | DZ2976A1 (en) |
HK (1) | HK1041690A1 (en) |
PE (1) | PE20001355A1 (en) |
WO (1) | WO2000039115A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
AU1474801A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003513972A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
MXPA02009305A (en) | 2000-03-21 | 2003-03-12 | Smithkline Beecham Corp | Protease inhibitors. |
US6982263B2 (en) | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
EP1483241A4 (en) | 2002-03-08 | 2006-12-13 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
JP2008512461A (en) * | 2004-09-07 | 2008-04-24 | スミスクライン・ビーチャム・コーポレイション | New compounds |
JP5236293B2 (en) * | 2005-01-13 | 2013-07-17 | ブリストル−マイヤーズ スクイブ カンパニー | Substituted biaryl compounds as XIA factor inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2285A1 (en) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Cysteine protease inhibitors. |
HUP0001285A3 (en) * | 1997-05-08 | 2000-10-30 | Smithkline Beecham Corp Philap | Pyrrolidine derivatives as protease inhibitors, process for producing them and pharmaceutical compositions containing them |
-
1999
- 1999-12-16 CO CO99078651A patent/CO5180541A1/en not_active Application Discontinuation
- 1999-12-21 JP JP2000591026A patent/JP2002533452A/en not_active Withdrawn
- 1999-12-21 EP EP99968936A patent/EP1140897A4/en not_active Withdrawn
- 1999-12-21 AU AU27131/00A patent/AU2713100A/en not_active Abandoned
- 1999-12-21 AR ARP990106647A patent/AR021970A1/en unknown
- 1999-12-21 WO PCT/US1999/030602 patent/WO2000039115A1/en not_active Application Discontinuation
- 1999-12-22 DZ DZ990276A patent/DZ2976A1/en active
- 1999-12-23 PE PE1999001311A patent/PE20001355A1/en not_active Application Discontinuation
-
2002
- 2002-02-19 HK HK02101209.3A patent/HK1041690A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1140897A1 (en) | 2001-10-10 |
DZ2976A1 (en) | 2004-03-15 |
WO2000039115A1 (en) | 2000-07-06 |
CO5180541A1 (en) | 2002-07-30 |
JP2002533452A (en) | 2002-10-08 |
AR021970A1 (en) | 2002-09-04 |
HK1041690A1 (en) | 2002-07-19 |
PE20001355A1 (en) | 2001-01-28 |
EP1140897A4 (en) | 2002-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL349192A1 (en) | Protease inhibitors | |
AU7127298A (en) | Serine protease inhibitors | |
PL336625A1 (en) | Protease inhibitors | |
PL336589A1 (en) | Serinic protease inhibitors | |
AU4723799A (en) | Protease inhibitors | |
AU6007200A (en) | Cysteine protease inhibitors | |
IL132088A0 (en) | Protease inhibitors | |
AU1795697A (en) | Serine protease inhibitors | |
AU7139598A (en) | Protease inhibitors | |
PL337755A1 (en) | Protease inhibitors | |
AU1877597A (en) | Serine protease inhibitors | |
IL132629A0 (en) | Protease inhibitors | |
AU9059798A (en) | Urokinase inhibitors | |
AU4092799A (en) | Protease inhibitors | |
AU1393900A (en) | Morpholino-ethoxybenzofuran protease inhibitors | |
AU9110298A (en) | Protease inhibitors | |
AU2723099A (en) | Tryptase inhibitors | |
AU4229599A (en) | Protease inhibitor peptides | |
AU1588901A (en) | Protease inhibitors | |
AU4564499A (en) | Protease inhibitors | |
AU2713100A (en) | Protease inhibitors | |
AU9300298A (en) | Protease inhibitors | |
AU1474801A (en) | Protease inhibitors | |
AU4066900A (en) | Protease inhibitors | |
AU1474601A (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |